Logo-bi
BioImpacts. 2021;11(3): 199-207. doi: 10.34172/bi.2021.27
PMID: 34336608        PMCID: PMC8314031

Original Research

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy

Ranjita Misra 1 * ORCID, Bamadeb Patra 2, Sudha Varadharaj 2, Rama Shanker Verma 2 * ORCID

Cited by CrossRef: 7


1- Dinakar Y, Rajana N, Kumari N, Jain V, Mehra N. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer. AAPS PharmSciTech. 2023;24(8) [Crossref]
2- Torres Quintas S, Canha‐Borges A, Oliveira M, Sarmento B, Castro F. Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment. Small. 2023; [Crossref]
3- Cai L, Xu X, Chen W. The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems. Pharmaceutics. 2022;14(8):1647 [Crossref]
4- Vysyaraju N, Paul M, Ch S, Ghosh B, Biswas S. Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer. Journal of Drug Targeting. 2022;:1 [Crossref]
5- Anwer M, Ali E, Iqbal M, Ahmed M, Aldawsari M, Saqr A, Alalaiwe A, Soliman G. Development of Chitosan-Coated PLGA-Based Nanoparticles for Improved Oral Olaparib Delivery: In Vitro Characterization, and In Vivo Pharmacokinetic Studies. Processes. 2022;10(7):1329 [Crossref]
6- Parthiban A, Sachithanandam V, Sarangapany S, Misra R, Muthukrishnan P, Jeyakumar T, Purvaja R, Ramesh R. Green synthesis of gold nanoparticles using quercetin biomolecule from mangrove plant, Ceriops tagal: Assessment of antiproliferative properties, cellular uptake and DFT studies. Journal of Molecular Structure. 2023;1272:134167 [Crossref]
7- Chaudhuri A, Kumar D, Dehari D, Patil R, Singh S, Kumar D, Agrawal A. Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology. Cancers. 2023;15(9):2661 [Crossref]
8- Sargazi S, Mukhtar M, Rahdar A, Barani M, Pandey S, Díez-Pascual A. Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review. IJMS. 2021;22(19):10319 [Crossref]
9- Quijia C, Enríquez A, Zappia C, Peroni R, Chorilli M. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy. CMC. 2024;31(6):726 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge